More than a period tracker. A daily guide to how your ovarian hormones actually run your life.
A YesPress company profile · Est. 2017 · MIT-founded
The mark. Aavia's wordmark in electric blue. The company started with a pill case that could tell whether you'd taken your pill - and grew, quietly, into something that reads your whole cycle.
Here is a fact that is either obvious or slightly scandalous, depending on how you think about markets: roughly half the people on earth have ovaries, their hormones move on a monthly cycle that affects mood, sleep, energy, skin and sex drive, and until recently almost none of the health technology was built with that cycle as the main character. Aavia, a Brooklyn company founded at MIT in 2017, decided this was not a niche. It was the market.
The founding is a nice piece of casting. Aagya Mathur, the CEO, has a neuroscience degree and an MIT Sloan MBA, and had been doing patient-experience consulting - the kind of work where you improve healthcare from a comfortable distance. She wanted to be closer to the person on the other end of the product. Aya Suzuki, the co-founder who runs design and experience, is an award-winning product designer. Alexis Wong is an electrical engineer with a patent to her name. An MBA, a designer, and an engineer, all from MIT, all with ovaries. If you were assembling a team to build hormone health hardware and software, you would struggle to draft a better one.
What they built first was hardware, which is the unusual part. Most software companies bolt on a device later, if ever. Aavia went the other way. The first product was a Smart Birth Control Pill Case: you slot your existing pill pack into a sensing sleeve, and patented sensors detect whether you've actually taken the pill at your set time. Over Bluetooth, the app nudges you until you do. It is a small, specific, useful thing - the kind of product that solves one problem so completely that it earns the right to solve bigger ones.
And the bigger one arrived. Aavia grew from that pill case into an all-in-one hormone health app. Members track mood, periods, discharge, body aches, medications and more, and the app returns science-backed education and personalized, cycle-based recommendations - what to eat, how to train, when to schedule the hard conversations and when to rest. The pitch, in Mathur's words, is to make your hormone cycle "a superpower rather than something they are dreading or feel is a burden." That is a big claim. The data underneath it is more modest and more convincing: 80% of members report improved symptom management within three weeks.
Log mood, periods, discharge, body aches and medications, and get AI-powered recommendations tied to where you are in your cycle - for nutrition, workouts, productivity, social time and rest. Science-backed education included. Women-owned, data-protected, FSA/HSA eligible.
The patented device that started it all. Slot your birth control pack into a sensing sleeve; sensors know whether you've taken your pill at your set time, and the app reminds you until you do. Around $79, U.S. shipping.
A trusted community of members plus a network of OB/GYNs and a medical advisory board who inform Aavia's education and personalized insights - so guidance is peer-tested and clinically grounded.
Tools and content aimed at healthcare providers, extending Aavia's cycle and hormone insights into the clinical setting to support patients between visits.
We see a world where people can use their hormone cycles to benefit them day to day - to make them a superpower rather than something they are dreading or feel is a burden.
A period app marks the day your period arrives. Aavia's bet is that the interesting signal is everything between those days - estrogen and progesterone rising and falling, and with them your energy, mood and focus. Track the wave, not just the edges.
Curves are illustrative, not member data.
Aavia launched publicly in January 2021 with a $2.5M seed, then added $3.7M in 2022 - including a check from Alexis Ohanian's Seven Seven Six - bringing the total to roughly $10M.
Backers include Seven Seven Six, Asset Management Ventures, Starting Line, January Ventures, Awesome People Ventures & Meridian Street Capital.
An MIT class project among three students becomes a company focused on hormone health.
Aavia launches its app and patented Smart Birth Control Pill Case with seed funding.
Profiled as "setting a new standard for hormone health."
Additional funding brings the total raised to roughly $10M.
The founding team is recognized on Forbes' 30 Under 30 for hormone health.
Aavia is a hormone health company building a daily app that helps people with ovaries understand how their ovarian hormones shape their energy, mood, sleep, skin, and sex drive across the cycle. Founded at MIT in 2017, it began with a patented Smart Birth Control Pill Case that senses whether you have taken your pill and reminds you until you do, then grew into an all-in-one tracking and education platform with personalized, science-backed insights, a member community, and a medical advisory board.
Last updated: